{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T23:46:04Z","timestamp":1761176764306,"version":"build-2065373602"},"reference-count":31,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Clinique et Biologique"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1016\/j.tracli.2008.06.002","type":"journal-article","created":{"date-parts":[[2008,8,31]],"date-time":"2008-08-31T06:01:02Z","timestamp":1220162462000},"page":"395-401","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Association of blood group A with early-onset ovarian hyperstimulation syndrome"],"prefix":"10.1016","volume":"15","author":[{"given":"H.","family":"Binder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.A.","family":"Flegel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Emran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Dittrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.W.","family":"Beckmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Zingsem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Eckstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Ringwald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tracli.2008.06.002_bib1","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1093\/humrep\/16.9.1880","article-title":"The questionable use of albumin for the prevention of ovarian hyperstimulation syndrome in an IVF programme: a randomized placebo-controlled trial","volume":"16","author":"Ben-Chetrit","year":"2001","journal-title":"Hum Reprod"},{"key":"10.1016\/j.tracli.2008.06.002_bib2","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1093\/humrep\/deg451","article-title":"Intravenous albumin does not prevent moderate\u2013severe ovarian hyperstimulation syndrome in high-risk IVF patients: a randomized controlled study","volume":"18","author":"Bellver","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.tracli.2008.06.002_bib3","doi-asserted-by":"crossref","first-page":"7297","DOI":"10.1056\/NEJMp038106","article-title":"The pathogenesis of the ovarian hyperstimulation syndrome","volume":"349","author":"Kaiser","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tracli.2008.06.002_bib4","first-page":"251","article-title":"Update on ovarian hyperstimulation syndrome: part 1 \u2014 incidence and pathogenesis","volume":"52","author":"Binder","year":"2007","journal-title":"Int J Fertil Womens Med"},{"year":"2006","series-title":"Ovarian hyperstimulation syndrome. Epidemiology, pathophysiology, prevention and management","author":"Rizk","key":"10.1016\/j.tracli.2008.06.002_bib5"},{"key":"10.1016\/j.tracli.2008.06.002_bib6","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0015-0282(16)43508-9","article-title":"Ovarian hyperstimulation syndrome: a current survey","volume":"30","author":"Schenker","year":"1978","journal-title":"Fertil Steril"},{"key":"10.1016\/j.tracli.2008.06.002_bib7","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.curobgyn.2005.01.003","article-title":"Prevention and management of ovarian hyperstimulation syndrome","volume":"15","author":"Mathur","year":"2005","journal-title":"Curr Obstet Gynaecol"},{"key":"10.1016\/j.tracli.2008.06.002_bib8","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/humupd\/dmg005","article-title":"Review of clinical course and treatment of ovarian hyperstimulation syndrome (OHSS)","volume":"9","author":"Delvigne","year":"2003","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.tracli.2008.06.002_bib9","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0015-0282(00)00492-1","article-title":"Distinction between early and late ovarian hyperstimulation syndrome","volume":"73","author":"Mathur","year":"2000","journal-title":"Fertil Steril"},{"key":"10.1016\/j.tracli.2008.06.002_bib10","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1093\/humrep\/deh638","article-title":"Early and late ovarian hyperstimulation syndrome: early pregnancy outcome and profile","volume":"20","author":"Papanikolaou","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.tracli.2008.06.002_bib11","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/ncpendmet0319","article-title":"Genetic predictors of ovarian hyperstimulation syndrome in women undergoing in vitro fertilization","volume":"2","author":"Delbaere","year":"2006","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"10.1016\/j.tracli.2008.06.002_bib12","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1530\/REP-07-0276","article-title":"Association of FSH receptor and CYP19A1 gene variations with sterility and ovarian hyperstimulation syndrome","volume":"135","author":"Binder","year":"2008","journal-title":"Reproduction"},{"key":"10.1016\/j.tracli.2008.06.002_bib13","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1054\/cuog.2001.0243","article-title":"Prevention and management of ovarian hyperstimulation syndrome","volume":"12","author":"Mathur","year":"2002","journal-title":"Curr Obstet Gynaecol"},{"key":"10.1016\/j.tracli.2008.06.002_bib14","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1093\/oxfordjournals.humrep.a137978","article-title":"Von Willebrand factor: an endothelial marker to monitor in-vitro fertilization patients with ovarian hyperstimulation syndrome","volume":"8","author":"Todorow","year":"1993","journal-title":"Hum Reprod"},{"key":"10.1016\/j.tracli.2008.06.002_bib15","doi-asserted-by":"crossref","unstructured":"Chan WS, Dixon ME. The \u201cART\u201d of thromboembolism: A review of assisted reproductive technology and thromboembolic complications. Thromb Res 2008;121(6):713\u201326.","DOI":"10.1016\/j.thromres.2007.05.023"},{"key":"10.1016\/j.tracli.2008.06.002_bib16","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3109\/08820139509062774","article-title":"Blood group antigens as tumor markers, parasitic\/bacterial\/viral receptors, and their association with immunologically important proteins","volume":"24","author":"Garratty","year":"1995","journal-title":"Immunol Invest"},{"key":"10.1016\/j.tracli.2008.06.002_bib17","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0140-6736(69)91925-4","article-title":"Venous thromboembolism and blood-group","volume":"1","author":"Nefzger","year":"1969","journal-title":"Lancet"},{"key":"10.1016\/j.tracli.2008.06.002_bib18","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0140-6736(70)90670-7","article-title":"Venous thromboembolism and blood-group","volume":"1","author":"Allan","year":"1970","journal-title":"Lancet"},{"key":"10.1016\/j.tracli.2008.06.002_bib19","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1046\/j.1365-3148.2001.00315.x","article-title":"The relationship between ABO histo-blood group, factor VIII and von Willebrand factor","volume":"11","author":"O\u2019Donnell","year":"2001","journal-title":"Transfus Med"},{"key":"10.1016\/j.tracli.2008.06.002_bib20","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1111\/j.1537-2995.2006.00975.x","article-title":"ABO blood group determines plasma von Willebrand factor levels: a biologic function after all?","volume":"46","author":"Jenkins","year":"2006","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2008.06.002_bib21","first-page":"23","article-title":"Distribution of ABO blood types among fertile and infertile women","volume":"21","author":"Solish","year":"1969","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.tracli.2008.06.002_bib22","first-page":"285","article-title":"Frequencies of the blood groups ABO, Rhesus, D category VI, Kell, and of clinically relevant high-frequency antigens in south-western Germany","volume":"22","author":"Wagner","year":"1995","journal-title":"Infusionsther Transfusionsmed"},{"key":"10.1016\/j.tracli.2008.06.002_bib23","first-page":"143","article-title":"ABO incompatibility and reproductive failure. I. Prenatal selection","volume":"36","author":"Schaap","year":"1984","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.tracli.2008.06.002_bib24","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000009924","article-title":"ABO blood group and expression of antisperm antibodies in infertile couples in Kuwait","volume":"45","author":"Omu","year":"1998","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.tracli.2008.06.002_bib25","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1023\/A:1026590910462","article-title":"A rise of the serum level of von Willebrand factor occurs before clinical manifestation of the severe form of ovarian hyperstimulation syndrome","volume":"18","author":"Ogawa","year":"2001","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.tracli.2008.06.002_bib26","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1182\/blood-2006-07-035105","article-title":"The effect of von Willebrand factor Y\/C1584 on in vivo protein level and function, and interaction with ABO blood group","volume":"109","author":"Davies","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.tracli.2008.06.002_bib27","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1111\/j.1538-7836.2006.02205.x","article-title":"Acute activation of the endothelium results in increased levels of active von Willebrand factor in hemolysis, elevated liver enzymes and low platelets (HELLP) syndrome","volume":"4","author":"Hulstein","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.tracli.2008.06.002_bib28","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ijcard.2006.03.011","article-title":"Differences in inflammatory and thrombotic markers between unstable angina and acute myocardial infarction","volume":"115","author":"Tousoulis","year":"2007","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.tracli.2008.06.002_bib29","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.transci.2006.02.004","article-title":"Update on pathogen reduction technology for therapeutic plasma: an overview","volume":"35","author":"Solheim","year":"2006","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.tracli.2008.06.002_bib30","doi-asserted-by":"crossref","first-page":"R126","DOI":"10.1186\/cc5037","article-title":"Biological markers of lung injury before and after the institution of positive pressure ventilation in patients with acute lung injury","volume":"10","author":"Cepkova","year":"2006","journal-title":"Crit Care"},{"key":"10.1016\/j.tracli.2008.06.002_bib31","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S1472-6483(10)60193-9","article-title":"Blood group A: an overseen risk factor for early-onset ovarian hyperstimulation syndrome?","volume":"17","author":"Binder","year":"2008","journal-title":"Reprod Biomed Online"}],"container-title":["Transfusion Clinique et Biologique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782008001523?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782008001523?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:30:26Z","timestamp":1761129026000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1246782008001523"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["S1246782008001523"],"URL":"https:\/\/doi.org\/10.1016\/j.tracli.2008.06.002","relation":{},"ISSN":["1246-7820"],"issn-type":[{"type":"print","value":"1246-7820"}],"subject":[],"published":{"date-parts":[[2008,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of blood group A with early-onset ovarian hyperstimulation syndrome","name":"articletitle","label":"Article Title"},{"value":"Transfusion Clinique et Biologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tracli.2008.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}